Profiel
Cynthia L.
Sundell worked as the Vice President of Pharmacology at AtheroGenics, Inc. from 1995 to 2009.
She also worked as the Vice President of Drug Development at ABIONYX Pharma SA.
Eerdere bekende functies van Cynthia L. Sundell
| Bedrijven | Functie | Einde |
|---|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Corporate Officer/Principal | 14-07-2009 |
| ABIONYX PHARMA | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
